ProKidney Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	60.65	490.25	20.56	4.58
Short-Term Investments	302.3	0	0	0
Cash & Cash Equivalents	362.95	490.25	20.56	4.58
Cash Growth	-25.97%	2284.73%	349.06%	-
Other Current Assets	11.2	14.47	6.71	1.01
Total Current Assets	374.15	504.72	27.27	5.59
Property, Plant & Equipment	46.41	13.06	12.6	10.47
Goodwill and Intangibles	0	0.21	0.43	0.64
Total Long-Term Assets	46.41	13.28	13.03	11.12
Total Assets	420.55	518	40.3	16.7
Accounts Payable	5.1	3.04	2.83	0.78
Current Debt	0.8	0.49	0.27	0.23
Other Current Liabilities	19.14	7.34	9.21	4.5
Total Current Liabilities	25.04	10.87	12.31	5.5
Long-Term Debt	3.61	1.91	1.07	1.33
Other Long-Term Liabilities	0.57	0.28	0	0
Total Long-Term Liabilities	4.18	2.18	1.07	1.33
Total Liabilities	29.22	13.06	13.38	6.84
Total Debt	4.41	2.4	1.33	1.56
Debt Growth	83.95%	79.84%	-14.43%	-
Retained Earnings	-1,139.66	-1,104.12	-161.51	-106.36
Comprehensive Income	0.13	0	0	0
Shareholders' Equity	-1,103.4	-1,096.62	26.92	9.86
Net Cash / Debt	358.54	487.85	19.22	3.02
Net Cash / Debt Growth	-26.51%	2437.73%	536.77%	-
Net Cash Per Share	5.81	7.93	0.13	0.03
Working Capital	349.11	493.85	14.96	0.08
Book Value Per Share	-17.88	-17.82	0.18	0.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).